Colonoscopy is the gold standard for detecting colon cancer, but every year about 50 million people in the U.S. who qualify for a colonoscopy don't get it done, according to the American Cancer ...

For the first time, the U.S. Food and Drug Administration has approved a blood test as a primary screening option for colorectal cancer. Guardant Health's Shield blood test was approved Monday as a ...

Stool DNA testing climbed sharply after the pandemic began while colonoscopy and fecal immunochemical test use fell, a study of nearly 25 million privately insured Blue Cross Blue Shield beneficiaries ...

Colon Cancer Screening: The test could increase the number of patients who receive screening for colorectal cancer. The Food and Drug Administration (FDA) has approved a new colorectal cancer (CRC) ...

The test detects cancer by detecting DNA shed by tumors in blood samples. The U.S. Food and Drug Administration on Monday morning approved a blood test to screen for colorectal cancer in certain ...

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

Guardant Health grows with Shield blood CRC screening, Quest deal, 50M reach, 335% surge, and FY25 revenue $981M up 33%. Read ...

Colorectal cancer used to be considered a cancer of older age. Not anymore.

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...

Doctors recommend screening for this disease starting at age 45.

A new report found that colorectal cancer is now the leading cause of cancer death in adults under 50, even as overall cancer ...